Loading clinical trials...
Loading clinical trials...
The purpose of this study is to find out about the safety of adding the investigational drug motexafin gadolinium to a standard course of chemotherapy with temozolomide for patients with malignant gli...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pharmacyclics LLC.
NCT07003542 · Glioblastoma, Brain Tumor
NCT05902169 · Glioblastoma, Recurrent Glioblastoma, and more
NCT05303467 · Glioblastoma Multiforme, Recurrent Glioblastoma
NCT04166409 · Low Grade Astrocytoma, Low Grade Glioma, and more
NCT05804227 · Gliomas
Barrow Neurological Institute
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions